drugset
drugset / Trial / NCT00365209

Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)

NCT00365209 ↗

Phase 2 Completed 44 enrolled National Cancer Institute (NCI)
Non-randomizedSingle-groupOpen-labelPrevention

Summary

Chemoprevention is the use of certain substances to keep cancer from forming, growing, or coming back. Curcumin is a compound found in plants that may prevent colon cancer from forming. This phase II trial is studying how well curcumin works in preventing colon cancer in smokers with aberrant crypt foci.

Timeline

Start
2006-10
Primary completion
2008-09
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Curcumin Small molecule 2 g Oral
Subject Curcumin Small molecule 4 g Oral

Indications

nicotine dependence